wordpress-1575231-6172732.cloudwaysapps.com https://validator.w3.org/feed/docs/rss2.html Enhancing Quality of Life Through Patient-Centered Innovation Home Decades of Expertise Driving the Future of Diabetes Treatment Our Story The Growing Global Challenge of Diabetes Rethinking Insulin Delivery for Modern Diabetes Care Capsulin Press Releases Diabetes Epidemic Oral GLP-1 Contact Corporate Social Responsibility News Disclaimer Terms of Use Privacy Policy Science Overview for Axcess Platform Advancing Science Through Long-Term Commitment Addressing Unmet Needs in Diabetes Care The Role of Innovation in Chronic Disease Management Why Drug Delivery Matters as Much as the Drug Overcoming Barriers to Oral Protein Delivery Building Technologies with Patients in Mind Supporting Consistency in Diabetes Treatment Shaping the Future of Diabetes Treatment Experience as a Foundation for Innovation Responding to the Rising Incidence of Diabetes The glucose lowering effect of an oral insulin during an isoglycaemic clamp study in persons with type 2 diabetes Perspectives on Commercialisation of Oral Insulin 2025 Oral Delivery of Biologics via the Intestine New et al 2024 GLP-1 receptor agonists for treatment of diabetes and obesity – advantage of oral delivery Safety and efficacy of an oral insulin (Capsulin) in patients withearly-stage type 2 diabetes: A dose-ranging phase 2b study Obesity Absorption of orally ingested insulin in human type 1 diabetic subjects New 2025 Oral Insulin – harnessing the natural physiology of glucose control in the body Programs